Advertisement
Advertisement
Google- LEXICON PHARMACEUTICALS, INC. : Lexicon Pharmaceuticals Provides Clinical ... - 4-traders
Started by
Health Reporter
, Feb 22 2012 07:38 AM
No replies to this topic
#1
Posted 22 February 2012 - 07:38 AM
LEXICON PHARMACEUTICALS, INC. : Lexicon Pharmaceuticals Provides Clinical ...4-tradersLX1033: In a Phase 1 study in healthy volunteers, LX1033, a serotonin synthesis inhibitor being developed as a treatment for irritable bowel syndrome (IBS), produced reductions in a biomarker of serotonin production (5-HIAA) comparable to those seen ...Lexicon Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript |
|
Advertisement |
|


Forums
Facebook
Twitter
Pinterest
Google+









